NSEBSECOMMODITYNASDAQNYSEFOREXINDICESAMEXUSA .

Famous Munafa Ebook, free scanners! Intraday scanner, FNO scanner, High profit BTST stocks!

Alnylam Pharmaceuticals (ALNY) Technical (Analysis) Reports Alnylam Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Alnylam Pharmaceuticals (ALNY)

Technical Analysis Report for USA stock ALNY Alnylam Pharmaceuticals. Dated: 27 Oct 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange

If you are looking for Tomorrow's Movement Predictions for USA stock ALNY Alnylam Pharmaceuticals then click here. or read Experts views on Alnylam Pharmaceuticals or Forecast & share price targets of Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Opened at 225.00 and Closed at: 226.79, which is -0.38% of previous session's close. It moved within a range of 222.82 and 228.49
The session was a Bullish session with an average volume of 1603400, which is 10.38% of previous session's volumes.

• The stock has fallen, and its short term trend is also negative and in a downtrend.
• There is some positive change in the mid term trend, but its too soon to jump onto conclusions.
• The stock has fallen, and its long term trend is also negative and in a downtrend.

A Golden cross was found 1 days back on short term averages

Support for tomorrow is 224.81 and resistance for tomorrow is 230.48
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 223.58, 220.36 resistance for tomorrow's hourly charts is 229.25, 231.7

10 Day SMA for Alnylam Pharmaceuticals (ALNY) is 228.53 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Alnylam Pharmaceuticals (ALNY) is 227.96 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Alnylam Pharmaceuticals (ALNY) is 239.08 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 255.02 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Alnylam Pharmaceuticals is 287.57 and stock is trading below these levels. This is not a good sign for its long term trend

20 DMA of Alnylam Pharmaceuticals is at 227.96 and 200 DMA is at 287.57, while 50 DMA and 100 DMA are at 239.08 and 255.02 respectively

Alnylam Pharmaceuticals (ALNY) moving average of 20 SMA is at 227.96 and 20 EMA is at 230.55

Alnylam Pharmaceuticals (ALNY) moving average of 50 SMA is at 239.08 and 50 EMA is at 238.83

Alnylam Pharmaceuticals (ALNY) moving average of 100 SMA is at 255.02 and 100 EMA is at 255.13

Alnylam Pharmaceuticals (ALNY) moving average of 200 SMA is at 287.57 and 200 EMA is at 281.29

Zoetis Inc has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Zoetis Inc, about 20.12% more returns!

Msa Safety has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Msa Safety, about 8.82% more returns!

Humana Inc has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Humana Inc, about 16.81% more returns!

Quest Diagnostics has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Quest Diagnostics, about 12.16% more returns!

Cvs Health has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Cvs Health, about 14.42% more returns!

Bristol Myers has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Bristol Myers, about 6.73% more returns!

Utah Medical has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Utah Medical, about 6.75% more returns!

Staar Surgical has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Staar Surgical, about 14.95% more returns!

Alnylam Pharmaceuticals has performed better than Summit Therapeutics in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!

Alnylam Pharmaceuticals has performed better than Regenxbio Inc in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!

Radnet Inc has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Radnet Inc, about 14.76% more returns!

Protagonist Therapeutics has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Protagonist Therapeutics, about 8.25% more returns!

Medpace Holdings has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Medpace Holdings, about 16.04% more returns!

Liquidia Technologies has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Liquidia Technologies, about 58.22% more returns!

Icu Medical has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Icu Medical, about 9.77% more returns!

Alnylam Pharmaceuticals has performed better than Galectin Therapeutics in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!

Fennec Pharmaceuticals has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Fennec Pharmaceuticals, about 7.81% more returns!

Biocryst Pharmaceuticals has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Biocryst Pharmaceuticals, about 5.21% more returns!

Alnylam Pharmaceuticals has performed better than Arrowhead Pharmaceuticals in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!

Alnylam Pharmaceuticals Technical analysis of indicators

Price action analysis of Alnylam Pharmaceuticals (ALNY) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.

ADX buy sell signal for Alnylam Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.

MACD generated a BUY signal for Alnylam Pharmaceuticals in short term but the buy signal is initial and weak.

MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

Alnylam Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a SELL signal for Alnylam Pharmaceuticals in short term and SELL signal is strong!

RSI is generating a SELL signal in short term but selling is losing momentum.

MRSI is in positive zone. This is a BUY zone

Stock of Alnylam Pharmaceuticals is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 228.69 and Alnylam Pharmaceuticals ALNY stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.

People seem to be coming out and selling the Alnylam Pharmaceuticals ALNY stock. Volume based technical analysis of Alnylam Pharmaceuticals ALNY stock is negative.

Alnylam Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for USA stock ALNY Alnylam Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And ALNY Experts View which covers a lot of information including buying and selling signals

ALNY future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Alnylam Pharmaceuticals or View Candle Stick Charts here

Share on: WhatsApp Facebook Tweet